Have your say - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Have your say


Pharmaceutical Technology Europe
Volume 21, Issue 11


Fedra Pavlou
November is finally upon us and the days are getting colder and shorter. Fortunately for the PTE team, we managed to escape the miserable weather of the UK for some days last month when we visited sunny Madrid for the annual CPhI/ICSE exhibition. This was the first time that I had the opportunity to attend the show and I have to say, although it was a tiring few days, I was lucky to meet some very interesting people and to learn about exciting developments in the pharmaceutical ingredients market. From advances in excipients to exciting innovations in drug delivery, the exhibition provided us with an excellent overview of the current market for pharmaceutical ingredients and the issues and challenges faced by manufacturers. One thing I can say is that, although the economic downturn has affected all industries, the sense of optimism amongst members of our industry is refreshing, and the commitment to development and innovation appears to have remained intact. Over the coming months, we will be reporting on some of the key developments in the ingredients industry and highlights from the show, so watch this space.

In this month's issue, we have taken a detailed look at the ever-evolving market for pharmaceutical packaging. For this feature, the PTE team worked with a number of experts to provide you with an overview of today's market for pharmaceutical packaging. We also uncovered some of the obstacles facing packaging manufacturers and looked at innovations and growth opportunities.

As you know from some of my previous communications, PTE recently set up a LinkedIn group ( http://pharmtech.com/linkedin), which is growing day-by-day. The first aim of this group was to allow us to connect with our readers and other experts within the industry, enabling us to get to know our audience, and to provide you with the latest developments in your industry. The second aim of the group was to allow you to connect with each other. In this issue, although it will not be obvious to most, some of the benefits of setting up this valuable network of experts can be seen; several of our LinkedIn group members provided some very valuable insight and contributions for our packaging feature. We will continue to report on the key issues in your industry and we will continue to encourage our LinkedIn group members to get involved. So if you have something to say and want to join in, feel free to sign up to our group ( http://pharmtech.com/linkedin).

Once again, I would like to thank you so much for your continued support of PTE. It has been a real pleasure to meet with some of you over the last few months and I look forward to meeting more new faces. Next stop for us: Los Angeles for this month's AAPS meeting. Maybe I'll see you there!

Best wishes, Fedra Pavlou

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
How does your company apply quality-by-design (QbD) principles to manufacturing processes?
To all processes for both new and legacy products
To all process for new products only
To select process for new products only
To select processes for both new and legacy products
Do not use QbD
To all processes for both new and legacy products
21%
To all process for new products only
11%
To select process for new products only
25%
To select processes for both new and legacy products
21%
Do not use QbD
23%
View Results
UPCOMING CONFERENCES

Programs for Investigational and Pre-Launch Drugs
Philadelphia, PA
July 17-18, 2013
Request Brochure

Strategic Pipeline Planning & Portfolio Valuation
Philadelphia, PA
August 13-14, 2013
Request Brochure

MES 2013 - Forum on Manufacturing Execution Systems
Philadelphia, PA
August 14-15, 2013
Request Brochure

Mobile Innovation for the Life Sciences Industry
Philadelphia, PA
August 20-21, 2013
Request Brochure

See All Conferences >>

Eric Langer Outsourcing Outlook Eric LangerOutsourcing's Modest Role as a Cost-Containment Strategy
Patricia Van Arnum Ingredients Insider Patricia Van ArnumIntellectual Property Battles in Solid-State Chemistry
Nathan Jessop Industry Insider Nathan Jessop Campaign Against Counterfeit Drugs Continues
Lynn Torbeck Statistical Solutions Lynn D. TorbeckCompositing Samples and the Risk to Product Quality
 More
Inadequate Access to Medicines Puts EU at Risk
FDA Offers Insight on QbD for Modified-Release Products
Global Biosimilars Market to Reach $2.445 Billion in 2013
Adapting to Change
AstraZeneca and Exco InTouch Collaborate to Augment Current COPD Pathways
FindPharma Custom Search
Source: Pharmaceutical Technology Europe,
Click here